Improving brain-computer interfaces for restoring movement in paralyzed individuals
Optimizing co-adaptation in motor BCIs by uncovering brain-decoder interactions
This study is looking at how to make brain-computer interfaces better at helping people who are paralyzed move again by understanding how the brain's signals can be turned into movement commands, using animal models to find ways to improve these devices for long-term use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10935970 on NIH RePORTER |
What this research studies
This research investigates how brain-computer interfaces (BCIs) can be optimized to restore movement in people who are paralyzed. It focuses on understanding the interactions between brain activity and the algorithms that decode this activity into movement commands. By studying these interactions, the research aims to develop more reliable BCIs that can maintain performance over extended periods and in various settings. The approach involves using animal models to explore how changes in brain activity can be leveraged to enhance BCI functionality and robustness.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with paralysis who may benefit from advanced brain-computer interface technology.
Not a fit: Patients with conditions unrelated to paralysis or those who do not have the capacity to engage with BCI technology may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective BCIs that provide consistent movement restoration for paralyzed patients.
How similar studies have performed: Previous research has shown promise in optimizing brain-computer interfaces, but this approach of focusing on decoder-encoder interactions is relatively novel.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Orsborn, Amy L — University of Washington
- Study coordinator: Orsborn, Amy L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.